{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:32:52Z","timestamp":1790731972831,"version":"4.1.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Deep metabolomic, proteomic and immunologic phenotyping of patients suffering from an infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have matched a wide diversity of clinical symptoms with potential biomarkers for coronavirus disease 2019 (COVID-19). Several studies have described the role of small as well as complex molecules such as metabolites, cytokines, chemokines and lipoproteins during infection and in recovered patients. In fact, after an acute SARS-CoV-2 viral infection almost 10-20% of patients experience persistent symptoms post 12 weeks of recovery defined as long-term COVID-19 syndrome (LTCS) or long post-acute COVID-19 syndrome (PACS). Emerging evidence revealed that a dysregulated immune system and persisting inflammation could be one of the key drivers of LTCS. However, how these biomolecules altogether govern pathophysiology is largely underexplored. Thus, a clear understanding of how these parameters within an integrated fashion could predict the disease course would help to stratify LTCS patients from acute COVID-19 or recovered patients. This could even allow to elucidation of a potential mechanistic role of these biomolecules during the disease course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study comprised subjects with acute COVID-19 (n=7; longitudinal), LTCS (n=33), Recov (n=12), and no history of positive testing (n=73).\n                      <jats:sup>1<\/jats:sup>\n                      H-NMR-based metabolomics with IVDr standard operating procedures verified and phenotyped all blood samples by quantifying 38 metabolites and 112 lipoprotein properties. Univariate and multivariate statistics identified NMR-based and cytokine changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we report on an integrated analysis of serum\/plasma by NMR spectroscopy and flow cytometry-based cytokines\/chemokines quantification in LTCS patients. We identified that in LTCS patients lactate and pyruvate were significantly different from either healthy controls (HC) or acute COVID-19 patients. Subsequently, correlation analysis in LTCS group only among cytokines and amino acids revealed that histidine and glutamine were uniquely attributed mainly with pro-inflammatory cytokines. Of note, triglycerides and several lipoproteins (apolipoproteins Apo-A1 and A2) in LTCS patients demonstrate COVID-19-like alterations compared with HC. Interestingly, LTCS and acute COVID-19 samples were distinguished mostly by their phenylalanine, 3-hydroxybutyrate (3-HB) and glucose concentrations, illustrating an imbalanced energy metabolism. Most of the cytokines and chemokines were present at low levels in LTCS patients compared with HC except for IL-18 chemokine, which tended to be higher in LTCS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The identification of these persisting plasma metabolites, lipoprotein and inflammation alterations will help to better stratify LTCS patients from other diseases and could help to predict ongoing severity of LTCS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1144224","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T10:02:11Z","timestamp":1683626531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Georgy","family":"Berezhnoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosi","family":"Bissinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kienzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"H\u00e4berle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"G\u00f6pel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","unstructured":"2020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925558","article-title":"Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation","volume":"13","author":"Ceballos","year":"2022","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01020-4","article-title":"Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19","volume":"40","author":"Lee","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07147","article-title":"SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells","volume":"7","author":"Singh","year":"2021","journal-title":"Heliyon"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100068","article-title":"Metabolic defects of peripheral T cells in COVID-19 patients","volume":"206","author":"Liu","year":"2021","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"ltab013","DOI":"10.1093\/immadv\/ltab013","article-title":"Targeting immunometabolism to treat COVID-19","volume":"1","author":"O\u2019Carroll","year":"2021","journal-title":"Immunother Adv"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149626","article-title":"COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations","volume":"52","author":"Cornillet","year":"2022","journal-title":"Eur J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2100284","DOI":"10.1183\/13993003.00284-2021","article-title":"Metabolomic analyses reveal new stage-specific features of COVID-19","volume":"59","author":"Jia","year":"2022","journal-title":"Eur Respir J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.3390\/ijms23052414","article-title":"COVIDomics: the proteomic and metabolomic signatures of COVID-19","volume":"23","author":"Costanzo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-021-03540-y","article-title":"Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers","volume":"12","author":"Danlos","year":"2021","journal-title":"Cell Death Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa086","article-title":"Plasma metabolomic and lipidomic alterations associated with COVID-19","volume":"7","author":"Wu","year":"2020","journal-title":"Natl Sci Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00876","article-title":"NMR spectroscopic windows on the systemic effects of SARS-CoV-2 infection on plasma lipoproteins and metabolites in relation to circulating cytokines","volume":"20","author":"Lodge","year":"2021","journal-title":"J Proteome Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.746134","article-title":"Machine learning of serum metabolic patterns encodes asymptomatic SARS-CoV-2 infection","volume":"9","author":"Wan","year":"2021","journal-title":"Front Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00804","article-title":"Integration of transcriptome and metabolome provides unique insights to pathways associated with obese breast cancer patients","volume":"10","author":"Hassan","year":"2020","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","article-title":"Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19","volume":"183","author":"Su","year":"2020","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"338881","DOI":"10.1016\/j.aca.2021.338881","article-title":"Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients","volume":"1180","author":"He","year":"2021","journal-title":"Anal Chim Acta"},{"key":"B17","doi-asserted-by":"publisher","first-page":"338267","DOI":"10.1016\/j.aca.2021.338267","article-title":"The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes","volume":"1152","author":"Lv","year":"2021","journal-title":"Anal Chim Acta"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7150\/thno.61832","article-title":"Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1038\/s41467-021-24482-1","article-title":"The trans-omics landscape of COVID-19","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-022-00891-6","article-title":"Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients","volume":"7","author":"Song","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105896","article-title":"Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage","volume":"39","author":"Chen","year":"2020","journal-title":"EMBO J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e4637","DOI":"10.1002\/nbm.4637","article-title":"Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics","volume":"35","author":"Bizkarguenaga","year":"2022","journal-title":"NMR BioMed"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144734","article-title":"Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity","volume":"131","author":"Falck-Jones","year":"2021","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3390\/metabo12111026","article-title":"Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC)","volume":"12","author":"Guntur","year":"2022","journal-title":"Metabolites"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006076","article-title":"Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: a Brazilian study","volume":"13","author":"Correa","year":"2022","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.698337","article-title":"Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: current challenges and perspectives","volume":"8","author":"Letertre","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00519","article-title":"Integrative modeling of quantitative plasma lipoprotein, metabolic, and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2 infection","volume":"19","author":"Kimhofer","year":"2020","journal-title":"J Proteome Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.1c00977","article-title":"1H qNMR-based metabolomics discrimination of covid-19 severity","volume":"21","author":"Correia","year":"2022","journal-title":"J Proteome Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.839809","article-title":"Serum NMR profiling reveals differential alterations in the lipoproteome induced by pfizer-BioNTech vaccine in COVID-19 recovered subjects and na\u00efve subjects","volume":"9","author":"Ghini","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009243","article-title":"Metabolomic\/lipidomic profiling of COVID-19 and individual response to tocilizumab","volume":"17","author":"Meoni","year":"2021","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.1c00224","article-title":"Incomplete systemic recovery and metabolic phenoreversion in post-Acute-Phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome","volume":"20","author":"Holmes","year":"2021","journal-title":"J Proteome Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.1c00458","article-title":"Integrative modeling of plasma metabolic and lipoprotein biomarkers of SARS-CoV-2 infection in Spanish and Australian COVID-19 patient cohorts","volume":"20","author":"Masuda","year":"2021","journal-title":"J Proteome Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1039\/D2AN01097F","article-title":"Direct low field J-edited diffusional proton NMR spectroscopic measurement of COVID-19 inflammatory biomarkers in human serum","volume":"147","author":"Nitschke","year":"2022","journal-title":"Analyst"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.737039","article-title":"Metabolic and lipidomic markers differentiate COVID-19 from non-hospitalized and other intensive care patients","volume":"8","author":"Schmelter","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/metabo12121277","article-title":"Quantitative serum NMR spectroscopy stratifies COVID-19 patients and sheds light on interfaces of host metabolism and the immune response with cytokines and clinical parameters","volume":"12","author":"Rossler","year":"2022","journal-title":"Metabolites"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm069","article-title":"pcaMethods\u2013a bioconductor package providing PCA methods for incomplete data","volume":"23","author":"Stacklies","year":"2007","journal-title":"Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures","volume":"78","author":"Dieterle","year":"2006","journal-title":"Appl 1H NMR metabonom Anal Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/metabo11010044","article-title":"Comprehensive meta-analysis of COVID-19 global metabolomics datasets","volume":"11","author":"Pang","year":"2021","journal-title":"Metabolites"},{"key":"B42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","article-title":"NICE guideline on long COVID","volume":"9","author":"Venkatesan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/metabo12070618","article-title":"Severe COVID-19 is characterised by perturbations in plasma amines correlated with immune response markers, and linked to inflammation and oxidative stress","volume":"12","author":"Karu","year":"2022","journal-title":"Metabolites"},{"key":"B44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/metabo11100659","article-title":"SARS-CoV2 infection alters tryptophan catabolism and phospholipid metabolism","volume":"11","author":"Kaur","year":"2021","journal-title":"Metabolites"},{"key":"B45","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.mcpro.2021.100159","article-title":"Metabolic perturbation associated with COVID-19 disease severity and SARS-CoV-2 replication","volume":"20","author":"Krishnan","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/metabo12080713","article-title":"Metabolomics markers of COVID-19 are dependent on collection wave","volume":"12","author":"Lewis","year":"2022","journal-title":"Metabolites"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1021\/ac5025039","article-title":"Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for Large-scale metabolic phenotyping","volume":"86","author":"Dona","year":"2014","journal-title":"Anal Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.isci.2020.101645","article-title":"SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum","volume":"23","author":"Bruzzone","year":"2020","journal-title":"iScience"},{"key":"B49","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/s41598-018-35232-7","article-title":"Lipoprotein markers associated with disability from multiple sclerosis","volume":"8","author":"Gafson","year":"2018","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100369","DOI":"10.1016\/j.xcrm.2021.100369","article-title":"Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity","volume":"2","author":"Sindelar","year":"2021","journal-title":"Cell Rep Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"104612","DOI":"10.1016\/j.isci.2022.104612","article-title":"Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19","volume":"25","author":"Buyukozkan","year":"2022","journal-title":"iScience"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010443","article-title":"Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients","volume":"18","author":"Ghini","year":"2022","journal-title":"PloS Pathog"},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4195067","article-title":"Multi-omics provide evidence for an anti-inflammatory immune signature and metabolic alterations in patients with Long COVID Syndrome \u2013 an exploratory study","volume-title":"medRxiv, preprint","author":"Kovarik","year":"2022"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78200","article-title":"Post-acute sequelae of COVID-19: a metabolic perspective","volume":"11","author":"Scherer","year":"2022","journal-title":"Elife"},{"key":"B55","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"36749","DOI":"10.1038\/srep36749","article-title":"2-aminobutyric acid modulates glutathione homeostasis in the myocardium","volume":"6","author":"Irino","year":"2016","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"154739","DOI":"10.1016\/j.metabol.2021.154739","article-title":"The serum metabolome of COVID-19 patients is distinctive and predictive","volume":"118","author":"Shi","year":"2021","journal-title":"Metabolism"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00338-21","article-title":"Amino acid metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis","volume":"9","author":"Ansone","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/vaccines10010079","article-title":"Central obesity improvement and blood glucose reduction are associated with a stronger adaptive immune response following COVID-19 mRNA vaccine","volume":"10","author":"Watanabe","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12931-022-02075-w","article-title":"Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia","volume":"23","author":"Yan","year":"2022","journal-title":"Respir Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.07.004","article-title":"Myalgic Encephalomyelitis\/Chronic fatigue syndrome: essentials of diagnosis and management","volume":"96","author":"Bateman","year":"2021","journal-title":"Mayo Clinic Proc"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-021-00881-0","article-title":"The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case\u2013control study","volume":"29","author":"Mohajeri","year":"2021","journal-title":"Inflammopharmacology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.3390\/app11094231","article-title":"The ability to normalise energy metabolism in advanced COVID-19 disease seems to be one of the key factors determining the disease progression\u2013a metabolomic NMR study on blood plasma","volume":"11","author":"Baranovicova","year":"2021","journal-title":"Appl Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212144","article-title":"Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension","volume":"74","author":"Harbaum","year":"2019","journal-title":"Thorax"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1101\/2022.12.20.22283729","article-title":"Stratification of hypertensive COVID-19 patients by quantitative NMR spectroscopy of serum metabolites, lipoproteins, inflammation markers","author":"Kazenwadel","year":"2022","journal-title":"medRxiv"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.912579","article-title":"Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes","volume":"13","author":"Ceperuelo-Mallafre","year":"2022","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2021-1115","article-title":"Blood lactate concentration in COVID-19: a systematic literature review","volume":"60","author":"Carpen\u00e8","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","article-title":"Ultra-High-Throughput clinical proteomics reveals classifiers of COVID-19 infection","volume":"11","author":"Messner","year":"2020","journal-title":"Cell Syst"},{"key":"B71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1144224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T10:02:16Z","timestamp":1683626536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1144224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2023.1144224"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1144224","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.13.523998","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1144224"}}